|
|
Title | Creator | Date |
101 |
|
Ocular Myasthenia Gravis Associated With Thymic Amyloidosis | Kristin O. Chapman, MD, Debra M. Beneck, MD, Marc J. Dinkin, MD | 2016-03 |
102 |
|
Optic Neuropathy Due to Chronic Lymphocytic Leukemia Proven With Optic Nerve Sheath Biopsy | Khurrum Khan, BS, Amina I. Malik, MD, Sumayya J. Almarzouqi, MD, Michael L. Morgan, MD, Sushma Yalamanchili, MD, Patricia Chevez-Barrios, MD, Andrew G. Lee, MD | 2016-03 |
103 |
|
Optic Nerve Sheath Melanoma Presenting as a Central Retinal Vein Occlusion | Alexander Barash, MD, Patrick A. Sibony, MD, Nigel A. Stippa, BS,Nariman S. Boyle, MD, James E. Davis, MD | 2016-03 |
104 |
|
Homonymous Hemianopic Hyporeflective Retinal Abnormality on Infrared Confocal Scanning Laser Photography: A Novel Sign of Optic Tract Lesion | Mario L. R. Monteiro, MD, PhD, Rafael B. Araújo, MD, Ana C. F. Suzuki, MD,Leonardo P. Cunha, MD, PhD, Rony C. Preti, MD, PhD | 2016-03 |
105 |
|
Development of Dural Arteriovenous Fistulas After Cerebral Venous Sinus Thrombosis | Jonathan A. Micieli, MD, CM, Sheldon Derkatch, MD, Vitor M. Pereira, MD, Edward A. Margolin, MD | 2016-03 |
106 |
|
Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial | Martin W. ten Hove, MD, Deborah I. Friedman, MD, Anil D. Patel, MD, Isabella Irrcher, PhD, Michael Wall, MD, Michael P. McDermott, PhD, for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
107 |
|
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial | Kimberly E. Cello, BS, John L. Keltner, MD, Chris A. Johnson, PhD, Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
108 |
|
Chronic Myelogenous Leukemia Relapse Presenting With Central Nervous System Blast Crisis and Bilateral Optic Nerve Infiltration | Joyce N. Mbekeani, MD, FRCS, FRCOphth, Maaly Abdel Fattah, MD, PhD, Randa M. Al Nounou, MD, Wahiba Chebbo, MD, Mohammed Asif Dogar, MD | 2016-03 |
109 |
|
Lambert-Eaton Myasthenic Syndrome: Ocular Signs and Symptoms | Jeffery D. Young, MD, Jacqueline A. Leavitt, MD | 2016-03 |
110 |
|
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis | Sean M. Gratton, MD, Angela M. Herro, MD, William J. Feuer, MS, Byron L. Lam, MD | 2016-03 |
111 |
|
Relationship Between Age, Gender, and Race in Patients Presenting With Myasthenia Gravis With Only Ocular Manifestations | Jason H. Peragallo, MD, Elena Bitrian, MD, Mark J. Kupersmith, MD,Fritz Zimprich, MD, PhD, Thomas J. Whittaker, MD, JD, Michael S. Lee, MD,Beau B. Bruce, MD, PhD | 2016-03 |
112 |
|
Peripapillary Retinal Nerve Fiber Layer Thickness Corresponds to Drusen Location and Extent of Visual Field Defects in Superficial and Buried Optic Disc Drusen | Lasse Malmqvist, MD, Marianne Wegener, MD, Birgit A. Sander, MSc, PhD,Steffen Hamann, MD, PhD | 2016-03 |
113 |
|
The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait | Roy W. Beck, MD, PhD | 2016-03 |
114 |
|
Innocent Until Proven Guilty | Heather E. Moss, MD, PhD, Tiffani S. Stroup, DO, Amy Y. Lin, MD, Oliver W. Graf, MD, Aaron M. Halfpenny, DO, Howard L. Lipton, MD, Ari M. Blitz, MD, Tibor Valyi-Nagy, MD, PhD | 2016-03 |
115 |
|
Literature Commentary | Mark L. Moster, MD, M. Tariq Bhatti, MD | 2016-03 |
116 |
|
Neuro-Ophthalmology of Space Flight | Andrew G. Lee, MD, William J. Tarver, MD, Thomas H. Mader, MD, Col (R), Charles Robert Gibson, OD, Stephen F. Hart, MD, Christian A. Otto, MD, MMSc | 2016-03 |
117 |
|
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis | Silvana L. Costa, PhD, Óscar F. Gonçalves, PhD, Nancy D. Chiaravalloti, PhD, John DeLuca, PhD, Jorge Almeida, PhD | 2016-03 |
118 |
|
Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Comment | Thomas H. Mader, MD, C. Robert Gibson, OD, Stephen F. Hart, MD | 2016-03 |
119 |
|
Bariatric Surgery and the Neuro-Ophthalmologist | Heather E. Moss, MD, PhD | 2016-03 |
120 |
|
Books Received: Handbook of Neuroimaging for the Ophthalmologist | Michael S. Vaphiades, MD | 2016-03 |
121 |
|
Cilioretinal Artery Territory Infarction Associated With Papilledema in a Patient With Neurofibromatosis Type 2 | Omar A. Mahroo, PhD, FRCOphth, Moin D. Mohamed, PhD, FRCOphth, Elizabeth M. Graham, FRCOphth, Samantha S. Mann, MD, FRCOphth,Gordon T. Plant, MD, FRCP, Shazia K. Afridi, MRCP, PhD, Christopher J. Hammond, MD, FRCOphth | 2016-03 |
122 |
|
Delayed Development of Intracranial Hypertension After Discontinuation of Tetracycline Treatment for Acne Vulgaris | Christine Law, MD, Gary L. Yau, MD, Martin ten Hove, MEng, MD, FRCSC | 2016-03 |